sglt2 inhibitors vs glp-1 GLP1 Receptor Agonists SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog How Do SGLT2 (Sodium-Glucose Cotransporter

GLP-1-lkemedel som Ozempic ger lgre risk fr missbruk och beroende En stor studie bland ver 600 000 amerikanska veteraner visar att GLP-1-lkemedel var frknippade med 14 procent lgre risk att utveckla nya missbruksproblem

This consistent pattern across multiple trials suggests the dual agonist approach offers genuine advantages over single GLP-1 agonism

Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)

She wasnt